Trial Design and Informed Consent for a Clinic-Based Study With a Treatment as Usual Control Arm
Degenholtz, Howard B.
Parker, Lisa S.
Reynolds, Charles F., III
Ethics and Behavior 2002; 12(1): 43-62
Employing the National Institute of Mental Health-funded Prevention of Suicide in Primary Care Elderly Collaborative Trial as a case study, we discuss 2 sets of ethical issues: obtaining informed consent for a clinic-based intervention study and using treatment as usual (TAU) as the control condition. We then address these ethical issues in the context of the debate about the quality improvement efforts of health care organizations. Our analysis reveals the tension between ethics and scientific integrity involved with using TAU as a control condition and the difficulty in designing high-quality research in a community-based setting.
Showing items related by title, author, creator and subject.
Informed consent and subject motivation to participate in a large, population-based genomics study: the Marshfield Clinic Personalized Medicine Research Project McCarty, Catherine A.; Nair, Anuradha; Austin, Diane M.; Giampietro, Philip F. (2007)
How Informed Is Consent in Vulnerable Populations? Experience Using a Continuous Consent Process During the MDP301 Vaginal Microbicide Trial in Mwanza, Tanzania Vallely, Andrew; Lees, Shelley; Shagi, Charles; Kasindi, Stella; Soteli, Selephina; Kavit, Natujwa; Vallely, Lisa; McCormack, Sheena; Pool, Robert; Hayes, Richard J (Microbicides Development Programme (MDP), 2010-06-13)HIV prevention trials conducted among disadvantaged vulnerable at-risk populations in developing countries present unique ethical dilemmas. A key concern in bioethics is the validity of informed consent for trial participation ...
Parker, Frederick R.; Paine, Charles J. (1999)